NAVBQ (NAVBQ) Stock Price & Analysis
NAVBQ (NAVBQ) rose 0.00% to USD 0 as of June 10, 2026 at 07:08 UTC, according to Nexqual real-time market data.
NAVBQ last closed at USD 0; the session ranged USD 0–0 on volume of 162,034 shares. Market capitalization is $10,008, with a 52-week range of USD 0–0.04 (PNK). Source: Nexqual, June 10, 2026 at 07:08 UTC.
Key Statistics (as of June 10, 2026 at 07:08 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.04 |
| Volume | 162,034 shares |
| Market Cap | $10,008 |
| Exchange | PNK |
Technical Analysis (NAVBQ)
Nexqual's technical model rates NAVBQ "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:08 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (NAVBQ)
Wall Street analysts rate NAVBQ "None", per Nexqual as of June 10, 2026 at 07:08 UTC.
| Consensus Rating | None |
|---|
Earnings (NAVBQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2021-09-30 | USD -0.08 vs est -0.11 ▲ beat |
| 2021-06-30 | USD -0.09 vs est -0.09 ▲ beat |
| 2021-03-31 | USD -0.12 vs est -0.08 ▼ miss |
| 2020-12-31 | USD -0.11 vs est -0.12 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:08 UTC.
Financials & Fundamentals (NAVBQ)
| Total Revenue | $610 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | -1678791.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.56 |
| Total Cash | $3.86M |
| Total Debt | $1.26M |
| Free Cash Flow | $-7.77M |
Source: Nexqual, June 10, 2026 at 07:08 UTC.
Financial Health Score (NAVBQ)
Nexqual rates NAVBQ's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:08 UTC.
| Growth | Strong — Revenue +39% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $4M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$8M, burning cash |
| Efficiency | Mixed — No data |
Ownership (NAVBQ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 100.08M |
| Float | 68.23M |
| Short % of Float | +3.96% |
Source: Nexqual, June 10, 2026 at 07:08 UTC.
Leadership (NAVBQ)
NAVBQ is led by Craig A. Dais (age 58), CFO & Principal Accounting Officer, per Nexqual as of June 10, 2026 at 07:08 UTC.
| CFO & Principal Accounting Officer | Craig A. Dais (age 58) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMPE | Ampio Pharmaceuticals, Inc. | USD 0.18 | ▲ 0% |
| BGMSP | Bio Green Med Solution Inc. | USD 0.7 | ▲ 0.86% |
| IMUC | EOM Pharmaceutical Holdings Inc | USD 0.25 | ▲ 17.92% |
| PLX | Protalix BioTherapeutics, Inc. | USD 1.98 | ▼ 0.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:08 UTC. This page is informational and not investment advice.